HOME > ORGANIZATION
ORGANIZATION
- JMA to Call on PAFSC Committee to Review Once Again Switch-OTC of Epadel
November 27, 2012
- 27 JPMA Member Companies’ 1st Half Sales Up 2.1%
November 26, 2012
- JPMA to Compile “Code of Practice,” Eyeing Implementation from April
November 16, 2012
- JPMA Reprimands Mitsubishi Tanabe for GMP Violation by Benesis
November 16, 2012
- JSPE to Introduce Pharmacovigilance Specialist Certification System to Support RMPs
November 14, 2012
- Industry, Academia Launch Project to Raise Public Awareness of COPD
November 1, 2012
- Officials from MOPH of Thailand Receive Quality Control Training: JPMA’s Int’l Cooperation Activities
October 26, 2012
- 1st Graduates Under 6-Year Pharmacy Education System Push Up Percentage of Qualified Pharmacists among Applicants for This Year’s MR Exam: MREAC
October 24, 2012
- Nearly 1,200 Municipalities Cover Full Cost of HPV Vaccinations: Expert Organization Survey
October 23, 2012
- Former Benesis GMP Violation: Ueda Vows to “Root Out” Problems in JBPO
October 19, 2012
- JBPO Looks to Boost Japan’s Self-Sufficiency Ratio of Plasma Derivatives, Mulls Further Integration: Pres. Ueda
October 18, 2012
- Mr Kaiya of Kyokai Kenpo Optimistic About Reaching 30% Generic Drug Use Target
October 18, 2012
- Sino-Japanese Pharmaceutical Exchange Symposium to Be Postponed at Request of China: OPMA
October 15, 2012
- OPMA Temporarily Freezes JBPO’s Appointment as Its Board Member, FPMAJ’s Member of Board of Trustees
October 15, 2012
- Permanent New Drug Premium, Expanded R&D Tax Credits Needed to Encourage Innovation and Investment: FPMAJ Chairman Naito
October 12, 2012
- Price Gap between Long-Listed Products, Generics Necessary: FPMAJ Chairman Naito
October 11, 2012
- President Teshirogi of JPMA Stresses Need for Asian Countries to Cooperate in Drug Discovery
October 11, 2012
- Proposal to Unify Basic Dispensing Fees Could Be Taken Up Again: JPA Vice President Miura
October 10, 2012
- Life Science Budget in Japan Lacks Absolute Amount: JPMA President Teshirogi
October 10, 2012
- “Industry Also Needs to Consider” Distribution of Drug Expenditure: Former Administrative Vice Minister of Health Erikawa
October 5, 2012
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…